Startups

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

Summary

Seedtable Score
  • 17
Locations
Company Size
  • 11 to 50 employees
Last Stage Round
  • Series A

Total funding Amount

$31M

Fundraising History

  • May 01 '21 Series A
    $7M

Investors